Related Experiment Videos
Craniofacial hyperhidrosis successfully treated with topical glycopyrrolate
Join Y Luh1, Thomas A Blackwell
1Department of Internal Medicine, University of Texas Medical Branch at Galveston, 77555-0570, USA.
Southern Medical Journal
|July 30, 2002
Summary
Topical glycopyrrolate effectively treats craniofacial hyperhidrosis, reducing excessive facial sweating. This treatment offers a safe alternative with minimal side effects for managing this condition.
Area of Science:
- Dermatology
- Neurology
Background:
- Current craniofacial hyperhidrosis treatments like thoracic sympathectomy are limited.
- Oral medications have significant side effects.
Observation:
- A 27-year-old physician experienced severe facial sweating triggered by exertion or stress.
- Sweating was prominent on the forehead, nose, and upper lip.
Findings:
- Daily application of 0.5% topical glycopyrrolate significantly reduced facial sweating.
- The treatment remained effective after washing and showed no skin discomfort.
- Sweating returned upon discontinuation, confirming glycopyrrolate's efficacy.
Implications:
- Topical glycopyrrolate presents a promising, well-tolerated treatment for craniofacial hyperhidrosis.
- This approach offers a localized, effective solution with a favorable safety profile.